Nicholas P. Restifo
ORCID:0000-0003-4229-4580
发表论文 676 篇 · 总被引 98895 次 · h-index 152
代表论文
- LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling (2024 · Signal Transduction and Targeted Therapy · 被引 20)
- Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells (2023 · Cancer Research Communications · 被引 10)
- T cells lead the charge against solid tumors (2024 · Nature Cancer · 被引 7)
- Synthetic soldiers: Turning T cells into immortal warriors (2024 · The Journal of Experimental Medicine · 被引 4)
- Abstract 6593: Rejuvenation of tumor-infiltrating lymphocytes (TIL): A novel strategy to revitalize TIL antitumor function for cell therapy (2024 · Cancer Research · 被引 2)
- IMMClock reveals immune aging and T cell function at single-cell resolution (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)